FINGOLIMOD Devatis caps 0.25 mg 28 pce

7680684060021 CH-68406 L04AE01 01.99.0.

Reimbursement limitations:

GILENYA3

Traitement de la sclérose en plaques (SEP) récurrente-rémittente chez l’adulte. Première prescription par un neurologue.

FINGOLIMOD Devatis caps 0.25 mg 28 pce
FINGOLIMOD Devatis caps 0.25 mg 28 pce
FINGOLIMOD Devatis caps 0.25 mg 28 pce
1 / 3
google

Details

Product number
6840601
CPT
-
Packaging group
28
Unit
Kapsel(n)
Composition
fingolimodum 0.25 mg ut fingolimodi hydrochloridum, carmellosum calcicum, natrii stearylis fumaras corresp. natrium 0.0295 mg, Kapselhülle: gelatina, E 171, E 172 (flavum), Drucktinte: lacca, E 172 (nigrum), alcohol butylicus, aqua purificata, propylenglycolum, ethanolum, alcohol isopropylicus, ammoniae solutio 28 per centum, pro capsula.

Articles (1)

Fingolimod Devatis 0.25 mg, Kapseln
Kapseln
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
30/06/2025
Patient information leaflet
Français
30/06/2025
Patient information leaflet
Italien
30/06/2025
Professional SmPC
Allemand
30/06/2025
Professional SmPC
Français
30/06/2025
Professional SmPC
Italien
30/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
0.25 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.0295 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Devatis AG

6330 Cham

Authorization information

Swissmedic authorization number
68406
Drug name
Fingolimod Devatis, Kapseln
Galenic form
KAHA
ATC Code
L04AE01
Authorization status
Z
Dispensation category
B
First authorization
22/03/2022
Authorization expiration date
21/03/2027
IT number
01.99.0.
Domain
Human medicine
Field of application
Multiple Sklerose

Packaging details

Description (FR)
FINGOLIMOD Devatis caps 0.25 mg 28 pce
Description (DE)
FINGOLIMOD Devatis Kaps 0.25 mg 28 Stk
Market launch
22/03/2022
Narcotic (BTM)
No

Available generics

Fingolimod Devatis, Kapseln
CHF 430.25
View
Fingolimod Devatis, Kapseln
CHF 1464.85
View
Fingolimod-Mepha, Kapseln
CHF 430.25
View
Fingolimod-Mepha, Kapseln
CHF 1464.85
View
Fingolimod Sandoz, Kapseln
CHF 430.25
View
Fingolimod Sandoz, Kapseln
CHF 1464.85
View
Fingolimod Spirig HC, Kapseln
CHF 430.25
View
Fingolimod Spirig HC, Kapseln
CHF 1464.85
View

Other packaging sizes

FINGOLIMOD Devatis caps 0.25 mg 7 pce
7 KAP
View
FINGOLIMOD Devatis caps 0.5 mg 7 pce
7 KAP
View
FINGOLIMOD Devatis caps 0.5 mg 28 pce
28 KAP
View
FINGOLIMOD Devatis caps 0.5 mg 84 pce
84 KAP
View
FINGOLIMOD Devatis caps 0.5 mg 98 pce
98 KAP
View